Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

2.

Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.

Sagare AP, Bell RD, Zlokovic BV.

J Alzheimers Dis. 2013;33 Suppl 1:S87-100. Review.

3.

Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature.

Carnevale D, Mascio G, D'Andrea I, Fardella V, Bell RD, Branchi I, Pallante F, Zlokovic B, Yan SS, Lembo G.

Hypertension. 2012 Jul;60(1):188-97. doi: 10.1161/HYPERTENSIONAHA.112.195511.

4.

Diverse roles for VEGF-A in the nervous system.

Mackenzie F, Ruhrberg C.

Development. 2012 Apr;139(8):1371-80. doi: 10.1242/dev.072348. Review.

5.

Glucocorticoids can induce PTSD-like memory impairments in mice.

Kaouane N, Porte Y, Vallée M, Brayda-Bruno L, Mons N, Calandreau L, Marighetto A, Piazza PV, Desmedt A.

Science. 2012 Mar 23;335(6075):1510-3. doi: 10.1126/science.1207615.

6.

Piezo proteins are pore-forming subunits of mechanically activated channels.

Coste B, Xiao B, Santos JS, Syeda R, Grandl J, Spencer KS, Kim SE, Schmidt M, Mathur J, Dubin AE, Montal M, Patapoutian A.

Nature. 2012 Feb 19;483(7388):176-81. doi: 10.1038/nature10812.

7.

Spaceflight regulates ryanodine receptor subtype 1 in portal vein myocytes in the opposite way of hypertension.

Dabertrand F, Porte Y, Macrez N, Morel JL.

J Appl Physiol (1985). 2012 Feb;112(3):471-80. doi: 10.1152/japplphysiol.00733.2011.

8.

Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

Jain S, Goldstein DS.

Neurobiol Dis. 2012 Jun;46(3):572-80. doi: 10.1016/j.nbd.2011.10.025. Review.

9.

The impact and management of nonmotor symptoms of Parkinson's disease.

Lyons KE, Pahwa R.

Am J Manag Care. 2011 Oct;17 Suppl 12:S308-14. Review.

10.

Effects of hypoperfusion in Alzheimer's disease.

Austin BP, Nair VA, Meier TB, Xu G, Rowley HA, Carlsson CM, Johnson SC, Prabhakaran V.

J Alzheimers Dis. 2011;26 Suppl 3:123-33. doi: 10.3233/JAD-2011-0010. Review.

11.

VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease.

Wang P, Xie ZH, Guo YJ, Zhao CP, Jiang H, Song Y, Zhu ZY, Lai C, Xu SL, Bi JZ.

Biochem Biophys Res Commun. 2011 Aug 5;411(3):620-6. doi: 10.1016/j.bbrc.2011.07.003.

PMID:
21771586
12.

Stress response and humoral immune system alterations related to chronic hypergravity in mice.

Guéguinou N, Bojados M, Jamon M, Derradji H, Baatout S, Tschirhart E, Frippiat JP, Legrand-Frossi C.

Psychoneuroendocrinology. 2012 Jan;37(1):137-47. doi: 10.1016/j.psyneuen.2011.05.015.

PMID:
21724335
13.

Phosphodiesterases in the central nervous system: implications in mood and cognitive disorders.

Xu Y, Zhang HT, O'Donnell JM.

Handb Exp Pharmacol. 2011;(204):447-85. doi: 10.1007/978-3-642-17969-3_19. Review.

PMID:
21695652
14.

The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.

Ha AD, Brown CH, York MK, Jankovic J.

Parkinsonism Relat Disord. 2011 Sep;17(8):625-8. doi: 10.1016/j.parkreldis.2011.05.020.

PMID:
21689962
15.

Evidence that angiogenesis lags behind neuron and astrocyte growth in experience-dependent plasticity.

Wallace CS, Withers GS, Farnand A, Lobingier BT, McCleery EJ.

Dev Psychobiol. 2011 Jul;53(5):435-42. doi: 10.1002/dev.20559.

PMID:
21678391
16.

Perceptual upright: the relative effectiveness of dynamic and static images under different gravity States.

Jenkin MR, Dyde RT, Jenkin HL, Zacher JE, Harris LR.

Seeing Perceiving. 2011;24(1):53-64. doi: 10.1163/187847511X555292.

PMID:
21406155
17.

Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier.

Paris D, Bachmeier C, Patel N, Quadros A, Volmar CH, Laporte V, Ganey J, Beaulieu-Abdelahad D, Ait-Ghezala G, Crawford F, Mullan MJ.

Mol Med. 2011 Mar-Apr;17(3-4):149-62. doi: 10.2119/molmed.2010.00180.

18.

Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights.

Mazza M, Marano G, Traversi G, Bria P, Mazza S.

J Alzheimers Dis. 2011;23(3):375-89. doi: 10.3233/JAD-2010-090700. Review.

PMID:
21098977
19.

Glial and neuronal control of brain blood flow.

Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA.

Nature. 2010 Nov 11;468(7321):232-43. doi: 10.1038/nature09613. Review.

20.

Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV.

Neuron. 2010 Nov 4;68(3):409-27. doi: 10.1016/j.neuron.2010.09.043.

Items per page

Supplemental Content

Support Center